NEW YORK (GenomeWeb News) – Nanogen today said that it would file for Chapter 11 bankruptcy and sell substantially all of its assets to Elitech for $25.7 million.

Nanogen said that the filing does not affect the operations of Nanogen Advanced Diagnostics, its affiliate based in Milan, Italy. Although that affiliate is not part of the filing, Nanogen said that Elitech would acquire ownership of NAD as well.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.